Actively Recruiting
Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation
Led by University of Luebeck · Updated on 2024-08-29
350
Participants Needed
3
Research Sites
450 weeks
Total Duration
On this page
Sponsors
U
University of Luebeck
Lead Sponsor
I
IHF GmbH - Institut für Herzinfarktforschung
Collaborating Sponsor
AI-Summary
What this Trial Is About
Additional left atrial appendage isolation during balloon ablation for persistent or long-standing persistent atrial fibrillation can reduce atrial fibrillation reoccurrence within 3-12 months compared to balloon-based pulmonary vein isolation only.
CONDITIONS
Official Title
Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Persistent or long-standing persistent atrial fibrillation (continuous AF sustained >7 days or >12 months)
- Age between 18 and 80 years
- Indication for atrial fibrillation ablation according to current guidelines
You will not qualify if you...
- Missing informed consent
- Left atrial appendage diameter greater than 25 mm measured 10 mm from the circumflex artery by TEE
- Paroxysmal atrial fibrillation
- Long-standing persistent atrial fibrillation with continuous duration over 4 years
- Previous pulmonary vein isolation or MAZE surgery
- Previous left atrial appendage closure or surgical excision
- Left atrial diameter greater than 60 mm at baseline
- Presence of left atrial thrombus at baseline
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University Hospital Eppendorf, Hamburg, Germany
Hamburg, Free and Hanseatic City of Hamburg, Germany, 20251
Actively Recruiting
2
Asklepios Klinik Altona
Hamburg, Free and Hanseatic City of Hamburg, Germany, 22763
Actively Recruiting
3
Clinic for Rhythmologiy Luebeck, Schleswig-Holstein Germany
Lübeck, Schleswig-Holstein, Germany, 23538
Actively Recruiting
Research Team
R
Roland Tilz, Prof. Dr.
CONTACT
C
Charlotte Eitel, Prof. Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here